Underlying comorbidity | ACC/AHA[1] | ESC/ESH[2] | CHEP[3] | NHFA[4] | JHS[5] | NICE[6] | ACP/AAFP[7] | ADA[8] | KDIGO[9] |
Established atherosclerotic cardiovascular disease* | <130/80 | <130/80 | <120/80 | <120/80 | <130/80 | <140/90 | |||
Heart failure | <130/80 | <130/80 | <120/80 | <120/80 | <130/80 | <140/90 | |||
Diabetes mellitus | <130/80 | <130/80 | <130/80 | <120/80 | <130/80 | <140/90 | <140/90¶ | ||
Chronic kidney disease | <130/80 | <130/80 | <120/80 | <120/80 | <130/80 | <140/90 | <120/80 | ||
High cardiovascular riskΔ | <130/80 | <130/80 | <120/80 | <120/80 | <130/80 | <140/90 | |||
Older adults◊ | <130/80 | <140/80 | <120/80 | <120/80 | <140/90 | <140/90 | <150/90§ | ||
No comorbidity | <130/80 | <130/80 | <140/90 | <140/90 | <130/80 | <140/90 |
All targets listed are predicated on therapy being well tolerated. (In general, if a patient cannot tolerate the target blood pressure, then the target must be adjusted upward.)
All values are in mmHg. All targets assume that blood pressure is monitored optimally (eg, with standardized office measurement, automated oscillometric blood pressure monitoring).ACC/AHA: American College of Cardiology/American Heart Association; ACP/AAFP: American College of Physicians/American Academy of Family Physicians; ADA: American Diabetes Association; CHEP: Canadian Hypertension Education Program; ESC/ESH: European Society of Cardiology/European Society of Hypertension; JHS: Japanese Hypertension Society; KDIGO: Kidney Disease Improving Global Outcomes; MI: myocardial infarction; NHFA: National Heart Foundation of Australia; NICE: National Institute for Health and Care Excellence (United Kingdom).
* Established atherosclerotic cardiovascular disease includes patients with prior MI, stroke, and peripheral artery disease.
¶ ADA suggests a lower target (<130/80) mmHg in patients with diabetes at high cardiovascular risk.
Δ Defined as an elevated calculated 10-year risk of having an atherosclerotic cardiovascular event; "elevated" in this context often means ≥10 or ≥15% 10-year risk.
◊ CHEP and JHS define older adults as ≥75 years, ACP/AAFP defines older adults as ≥60 years, and other societies define older adults as ≥65 years.
§ ACP/AAFP suggests a target of <140/90 mmHg in older adults with high cardiovascular risk.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟